硝苯地平可增强沙丁胺醇的支气管扩张作用。
Nifedipine enhances the bronchodilator effect of salbutamol.
作者信息
Lever A M, Corris P A, Gibson G J
出版信息
Thorax. 1984 Aug;39(8):576-8. doi: 10.1136/thx.39.8.576.
Abstract
Ten male asthmatic volunteers each inhaled two puffs (200 micrograms) of salbutamol on two separate days 30 minutes after double blind oral administration of either 20 mg nifedipine or identical placebo. FEV1 was recorded before and at intervals for four hours after inhalation of salbutamol. Overall the FEV1 was significantly greater during the four hour period after premedication with nifedipine (p less than 0.025) and the difference between the effects of placebo and nifedipine was greatest four hours after salbutamol (p less than 0.005). These results suggest that nifedipine prolongs the bronchodilator action of salbutamol in vivo.
摘要
十名男性哮喘志愿者在双盲口服20毫克硝苯地平或相同安慰剂30分钟后的两天，分别吸入两喷（200微克）沙丁胺醇。在吸入沙丁胺醇之前及之后的四小时内每隔一段时间记录第一秒用力呼气量（FEV1）。总体而言，硝苯地平预处理后的四小时内FEV1显著更高（p<0.025），安慰剂和硝苯地平作用之间的差异在吸入沙丁胺醇后四小时最大（p<0.005）。这些结果表明硝苯地平在体内可延长沙丁胺醇的支气管扩张作用。
相似文献
1
Nifedipine enhances the bronchodilator effect of salbutamol.硝苯地平可增强沙丁胺醇的支气管扩张作用。
Thorax. 1984 Aug;39(8):576-8. doi: 10.1136/thx.39.8.576.
2
Effect of ketotifen on the bronchodilation induced by salbutamol.
Respiration. 1988;54(3):190-2. doi: 10.1159/000195520.
3
Effect of nifedipine on salbutamol-induced bronchodilation in partially reversible airway obstruction.
Int J Clin Pharmacol Res. 1986;6(5):409-13.
4
Nifedipine in asthma. Dose-related effect on resting bronchial tone.
Chest. 1987 May;91(5):667-70. doi: 10.1378/chest.91.5.667.
5
Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).中性内肽酶抑制剂吸入性硫奥芬对吸入性心房利钠肽（ANP）支气管扩张反应的影响。
Thorax. 1996 Jan;51(1):71-4. doi: 10.1136/thx.51.1.71.
6
Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.吸入用非诺特罗与沙丁胺醇对哮喘患者气道和全身作用相对效能的比较。
Thorax. 1995 Jan;50(1):54-61. doi: 10.1136/thx.50.1.54.
7
Duration of preventive effect of inhaled salbutamol on early airway response to allergen in asthmatic subjects.
Respir Med. 1993 Feb;87(2):121-6. doi: 10.1016/0954-6111(93)90139-q.
8
Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids.
Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):325-32. doi: 10.1164/ajrccm.151.2.7842186.
9
Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.沙美特罗，一种新型长效吸入型β2肾上腺素能受体激动剂：与沙丁胺醇在成年哮喘患者中的比较。
Thorax. 1988 Sep;43(9):674-8. doi: 10.1136/thx.43.9.674.
10
A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.沙美特罗与沙丁胺醇对哮喘患者的十二个月比较。欧洲研究小组。
Eur Respir J. 1992 Oct;5(9):1062-7.
引用本文的文献
1
Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations.钙通道阻滞剂作为保胎药：作用原理、不良反应和治疗组合。
Pharmaceuticals (Basel). 2013 May 23;6(6):689-99. doi: 10.3390/ph6060689.
2
Efficacy of calcium channel blockers as maintenance therapy for asthma.钙通道阻滞剂作为哮喘维持治疗的疗效。
Br J Clin Pharmacol. 2002 Mar;53(3):243-9. doi: 10.1046/j.0306-5251.2001.01560.x.
3
Calcium antagonists. Drug interactions of clinical significance.钙拮抗剂。具有临床意义的药物相互作用。
Drug Saf. 1995 Sep;13(3):157-87. doi: 10.2165/00002018-199513030-00003.
4
Nifedipine enhances the bronchodilator effect of salbutamol.硝苯地平可增强沙丁胺醇的支气管扩张作用。
Thorax. 1985 May;40(5):399. doi: 10.1136/thx.40.5.399.
5
Clinical studies with calcium antagonists in asthma.钙拮抗剂在哮喘中的临床研究。
Br J Clin Pharmacol. 1985;20 Suppl 2(Suppl 2):289S-298S. doi: 10.1111/j.1365-2125.1985.tb02815.x.
6
Effect of nifedipine on serum theophylline concentrations and asthma control.硝苯地平对血清茶碱浓度及哮喘控制的影响。
Thorax. 1987 Oct;42(10):794-6. doi: 10.1136/thx.42.10.794.
7
Calcium antagonists--adverse drug interactions.钙拮抗剂——药物不良相互作用
Cardiovasc Drugs Ther. 1987 Dec;1(4):403-9. doi: 10.1007/BF02209082.
8
Salbutamol in the 1980s. A reappraisal of its clinical efficacy.20世纪80年代的沙丁胺醇。对其临床疗效的重新评估。
Drugs. 1989 Jul;38(1):77-122. doi: 10.2165/00003495-198938010-00004.
9
Calcium channel blockers and asthma.钙通道阻滞剂与哮喘
Lung. 1986;164(1):1-16. doi: 10.1007/BF02713625.
10
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.硝苯地平。对其在缺血性心脏病、高血压及相关心血管疾病中的药效学、药代动力学特性及治疗效果的综述。
Drugs. 1985 Sep;30(3):182-274. doi: 10.2165/00003495-198530030-00002.
本文引用的文献
1
Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.钙拮抗剂硝苯地平对运动诱发性哮喘的抑制作用。
Am Rev Respir Dis. 1981 Feb;123(2):156-60. doi: 10.1164/arrd.1981.123.2.156.
2
A calcium antagonist, nifedipine, modifies exercise-induced asthma.钙拮抗剂硝苯地平可改善运动诱发的哮喘。
Thorax. 1981 Oct;36(10):726-30. doi: 10.1136/thx.36.10.726.
3
Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma.硝苯地平对哮喘患者支气管运动张力和组胺反应性的影响。
Br Med J (Clin Res Ed). 1981 Aug 1;283(6287):348. doi: 10.1136/bmj.283.6287.348.
4
Nifedipine in the prevention of asthma induced by exercise and histamine.硝苯地平预防运动及组胺诱发的哮喘。
Am Rev Respir Dis. 1983 Dec;128(6):991-2. doi: 10.1164/arrd.1983.128.6.991.
5
[Metabolism and effects of vasoactive substance in the lung. 10. Effects of calcium antagonist, verapamil, on the smooth muscle of the trachea].
Nihon Kyobu Shikkan Gakkai Zasshi. 1976 Sep;14(9):506-11.
6
Aerosol salbutamol administration by IPPB: lowest effective dose.间歇性正压通气雾化吸入沙丁胺醇：最低有效剂量
Thorax. 1978 Dec;33(6):689-93. doi: 10.1136/thx.33.6.689.
Zotero 插件